Karuna Therapeutics to Present at Upcoming Investor Conferences
September 03 2020 - 6:30AM
Business Wire
Karuna Therapeutics, Inc. (NASDAQ:KRTX), an innovative
clinical-stage biopharmaceutical company committed to developing
novel therapies with the potential to transform the lives of people
with disabling and potentially fatal neuropsychiatric disorders,
today announced that senior management will participate in the
following upcoming virtual investor conferences:
Citi’s 15th Annual BioPharma Virtual Conference Date:
Wednesday, September 9, 2020 Time: 2:25 p.m. EDT
Wells Fargo 2020 Virtual Healthcare Conference Date:
Thursday, September 10, 2020 Time: 9:20 a.m. EDT
Morgan Stanley 18th Annual Global Healthcare Conference
Date: Tuesday, September 15, 2020 Time: 3:30 p.m. EDT
A live webcast of the Wells Fargo presentation will be available
on the Investor Relations page of Karuna’s website at
investors.karunatx.com. A replay of the webcast will also be
archived for up to 90 days on Karuna’s website following the
conference.
About Karuna
Karuna is a clinical-stage biopharmaceutical company committed
to developing and delivering first-in-class therapies with the
potential to transform the lives of people with CNS disorders –
which remain among the most disabling and potentially fatal
disorders worldwide. Galvanized by the understanding that today’s
neuropsychiatric patients deserve better, Karuna’s mission is to
harness the untapped potential of the brain’s complex biology in
pursuit of novel therapeutic pathways that will advance the
standard of care. For more information, please visit
karunatx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200903005157/en/
Investors: Alexis Smith 518-338-8990
asmith@karunatx.com
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024